Dow Jones Newswires: Novartis to seek FDA approval for COVID-19 treatment after positive data

[view original post]

[unable to retrieve full-text content]Novartis AG and Molecular Partners AG on Monday reported positive topline data from their antiviral Covid-19 treatment ensovibep, and will seek …